Study day | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Treatment group | 0 | 7 | 14 | 21 | 28 | 35 | 42 | 49 | 56 | 63 | |
C (control) | Geometric Means | 42.2 a | 30.6 a | 49.0 a | 98.6 a | 94.7 a | 86.1 a | 74.7 a | 53.0 a | 39.7 a | 34.6 a |
Totals | 520 | 344 | 804 | 1,142 | 1,077 | 1,024 | 843 | 700 | 435 | 404 | |
B (spinosad) | Geometric Means | 47.5 a | 14.0 a | 15.4 b | 17.5 b | 2.2 b | 0.4 b | 1.8 b | 1.5 b | 0.3 b | 0.2 b |
Totals | 527 | 191 | 201 | 208 | 30 | 11 | 29 | 25 | 5 | 4 | |
% Reduction vs. Controls | - | 54.1% | 68.6% | 82.2% | 97.6% | 99.5% | 97.6% | 97.1% | 99.3% | 99.5% | |
A (imidacloprid + PPF) | Geometric Means | 47.7 a | 1.4 b | 1.3 c | 1.7 c | 0.3 c | 0.2 b | 0.4 c | 0.1 c | 0.0 b | 0.0 b |
Totals | 519 | 32 | 23 | 28 | 6 | 3 | 5 | 2 | 0 | 0 | |
% Reduction vs. Controls | - | 95.5% | 97.4% | 98.3% | 99.7% | 99.7% | 99.5% | 99.7% | 100% | 100% |